NCT05065866 2025-12-04Duvelisib in Combination With BMS-986345 in Lymphoid MalignancyH. Lee Moffitt Cancer Center and Research InstitutePhase 1 Completed14 enrolled
NCT05057247 2025-10-31Duvelisib Plus Docetaxel In Recurrent/Metastatic HNSCCDana-Farber Cancer InstitutePhase 2 Completed26 enrolled 23 charts